Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
This comprehensive resource covers product change evaluation, postmarket surveillance, audit/inspection compliance, and various other laws and regulations pertaining to maintaining a product on the market.
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
| 17 September 2012 | By Ansis Helmanis
New guidance on submitting periodic safety update reports (PSURs) for drugs was released by China's State Food and Drug Administration (SFDA) on 6 September. The guidance conforms to the harmonized PSUR standards developed by the International Conference on Harmonization [ICH E2C (R1)]. Foreign importers and joint ventures must submit Line Listings, summary tables (Summary Tabulations) and the company's core data table (Company Core Data Sheet, CCDS) translated into Chinese, together with the original English text report.
Read more:
SFDA - Standardization of regular basis safety update reports
Read all Breaking News from RegLink
Tags: ADRs, Period Safety Update Reports, PSURs, SFDA, Latest News, guidance